Biochemical Pharmacology,
Journal Year:
2024,
Volume and Issue:
228, P. 116258 - 116258
Published: May 3, 2024
Over
the
past
decade,
human
genome-wide
association
and
expression
studies
have
strongly
implicated
dysregulation
of
innate
immune
system
in
pathogenesis
Alzheimer's
disease
(AD).
Single
cell
mRNA
sequencing
identified
subtypes
that
are
minimally
present
normal
healthy
brain,
but
whose
numbers
greatly
increase
with
AD
pathology.
These
pathology-associated
cells
putatively
locus
for
immune-related
risk.
While
prevailing
view
is
these
arise
from
transformation
resident
brain
microglia,
across
several
decades
using
multiple
techniques
strategies
suggest
instead
bone-marrow
derived
hematopoietic
recruited
into
brain.
We
critically
review
this
translational
literature,
emphasizing
strengths
limitations
used
to
address
recruitment
experimental
designs
employed.
conclude
aggregate
evidence
points
toward
myeloid
dendritic
lineage.
Recruitment
their
role
has
broad
implications
our
understanding
etiology
pathobiology
impact
develop
new,
system-targeted
therapeutics
devastating
disease.
Seminars in Immunopathology,
Journal Year:
2024,
Volume and Issue:
46(1-2)
Published: July 1, 2024
Activation
of
the
maternal
immune
system
during
gestation
has
been
associated
with
an
increased
risk
for
neurodevelopmental
disorders
in
offspring,
particularly
schizophrenia
and
autism
spectrum
disorder.
Microglia,
tissue-resident
macrophages
central
nervous
system,
are
implicated
as
potential
mediators
this
risk.
Early
development,
microglia
start
populating
embryonic
addition
to
their
traditional
role
responders
under
homeostatic
conditions,
also
intricately
involved
various
early
processes.
The
timing
activation
may
interfere
functioning
neurodevelopment,
potentially
leading
long-term
consequences
postnatal
life.
In
review
we
will
discuss
involvement
brain
development
prenatal
stages
life,
while
examining
effects
on
Additionally,
recent
single
cell
RNA-sequencing
studies
focusing
hypothesize
how
life
microglial
priming,
through
epigenetic
reprogramming,
be
related
disorders.
Genome Medicine,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Aug. 2, 2024
Ischemic
stroke
elicits
a
complex
and
sustained
immune
response
in
the
brain.
Immunomodulatory
treatments
have
long
held
promise
for
improving
outcomes,
yet
none
succeeded
clinical
setting.
This
lack
of
success
is
largely
due
to
our
incomplete
understanding
how
cells
respond
stroke.
The
objective
current
study
was
dissect
effect
permanent
on
microglia,
resident
within
brain
parenchyma.
A
middle
cerebral
artery
occlusion
(pMCAO)
model
used
induce
ischemic
young
male
female
mice.
Microglia
were
sorted
from
fluorescence
reporter
mice
after
pMCAO
or
sham
surgery
then
subjected
single-cell
RNA
sequencing
analysis.
Various
methods,
including
flow
cytometry,
situ
hybridization,
immunohistochemistry,
whole-brain
imaging,
bone
marrow
transplantation,
also
employed
microglial
Stroke
outcomes
evaluated
by
infarct
size
behavioral
tests.
First,
we
showed
morphologic
spatial
changes
microglia
We
performed
analysis
isolated
both
sexes.
data
indicate
no
major
sexual
dimorphism
Notably,
identified
seven
potential
stroke-associated
clusters,
four
clusters
characterized
disease-associated
microglia-like
signature,
highly
proliferative
state,
macrophage-like
profile,
an
interferon
(IFN)
respectively.
Importantly,
provided
evidence
that
cluster
may
represent
long-sought
stroke-induced
subpopulation
with
increased
CD45
expression.
Lastly,
given
IFN-responsive
subset
constitutes
most
prominent
population
brain,
fludarabine
pharmacologically
target
STAT1
signaling
found
treatment
improved
long-term
outcome.
Our
findings
shed
new
light
heterogeneity
pathology
underscore
targeting
specific
populations
effective
therapies.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 24, 2025
Brain
macrophages
encompass
two
major
populations:
microglia
in
the
parenchyma
and
border-associated
(BAMs)
extra-parenchymal
compartments.
These
cells
play
crucial
roles
maintaining
brain
homeostasis
immune
surveillance.
Microglia
BAMs
are
phenotypically
epigenetically
distinct
exhibit
highly
specialized
functions
tailored
to
their
environmental
niches.
Intriguingly,
recent
studies
have
shown
that
both
originate
from
same
myeloid
progenitor
during
yolk
sac
hematopoiesis,
but
developmental
fates
diverge
within
brain.
Several
works
partially
unveiled
mechanisms
orchestrating
development
of
mice
humans;
however,
many
questions
remain
unanswered.
Defining
molecular
underpinnings
controlling
transcriptional
epigenetic
programs
is
one
upcoming
challenges
for
field.
In
this
review,
we
outline
current
knowledge
on
ontogeny,
phenotypic
diversity,
factors
shaping
ecosystem
macrophages.
We
discuss
insights
garnered
human
studies,
highlighting
similarities
differences
compared
mice.
Lastly,
address
research
gaps
potential
future
directions
Understanding
how
communicate
with
local
environment
tissue
instructs
trajectories
functional
features
essential
fully
comprehend
physiology
disease.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 31, 2025
SUMMARY
Single-cell
transcriptomic
studies
have
identified
distinct
microglial
subpopulations
with
shared
and
divergent
gene
signatures
across
development,
aging
disease.
Whether
these
subsets
represent
ontogenically
separate
lineages
of
cells,
or
they
are
manifestations
plastic
changes
states
downstream
some
converging
signals
is
unknown.
Furthermore,
despite
the
well-established
role
enhancer
landscapes
underlying
identity
microglia,
to
what
extent
histone
modifications
DNA
methylation
regulate
state
switches
at
enhancers
not
been
defined.
Here,
using
genetic
fate
mapping,
we
demonstrate
common
embryonic
origin
proliferative-region-associated
microglia
(PAM)
enriched
in
developing
white
matter,
track
their
dynamic
transitions
into
disease-associated
(DAM)
matter-associated
(WAM)
disease
contexts,
respectively.
This
study
links
spatiotemporally
discrete
through
epigenomic
plasticity,
while
revealing
state-specific
modification
profiles
that
govern
health
ABSTRACT
Background
Spinal
cord
injury
(SCI)
is
a
severe
condition
leading
to
significant
disability
and
high
mortality.
The
role
of
the
secreted
phosphoprotein
1
(SPP1)
signaling
pathway
in
SCI,
which
quickly
activated
after
injury,
critical
for
intercellular
communication
but
remains
poorly
understood.
Aims
This
study
aimed
explore
function
regulatory
mechanisms
SPP1
SCI
investigate
its
potential
as
therapeutic
target
improving
functional
recovery
injury.
Materials
Methods
Single‐cell
RNA
sequencing
(scRNA‐seq)
was
employed
identify
ligands
receptors
pathway,
particularly
microglia/macrophages.
Recombinant
(rSPP1)
used
vitro
vivo
assess
effects
on
neuronal
maturation,
mitochondrial
energy
axons,
SCI.
Pseudotime
analysis
conducted
examine
Spp1
microglial
activation
proliferation.
DNA‐pulldown
experiments
were
performed
upstream
proteins
.
Results
primarily
localized
microglia
with
rSPP1
promoting
maturation
enhancing
axons.
Injection
into
injured
spinal
resulted
improvement
recovery.
indicated
that
involved
proliferation
microglia.
Histone
H4
lysine
12
lactylation
(H4K12la)
found
promote
transcription
reprogrammed
postinjury.
Discussion
Our
findings
reveal
novel
mechanism
involving
activation,
function,
glycolytic
reprogramming.
new
insight
provides
deeper
understanding
contribution
response.
Conclusion
uncovers
previously
unreported
offering
Biomarker Research,
Journal Year:
2024,
Volume and Issue:
12(1)
Published: Sept. 13, 2024
Abstract
Background
Temporal
lobe
epilepsy
(TLE)
is
among
the
most
common
types
of
and
often
leads
to
cognitive,
emotional,
psychiatric
issues
due
frequent
seizures.
A
notable
pathological
change
related
TLE
hippocampal
sclerosis
(HS),
which
characterized
by
neuronal
loss,
gliosis,
an
increased
neuron
fibre
density.
The
mechanisms
underlying
TLE-HS
development
remain
unclear,
but
reactive
transcriptomic
changes
in
glial
cells
neurons
hippocampus
post-epileptogenesis
may
provide
insights.
Methods
To
induce
TLE,
200
nl
kainic
acid
(KA)
was
stereotactically
injected
into
CA1
region
mice,
followed
a
7-day
postinjection
period.
Single-cell
RNA
sequencing
(ScRNA-seq),
single-nucleus
(SnRNA-seq),
Xenium-based
spatial
transcriptomics
analyses
were
employed
evaluate
mRNA
expression
neurons.
Results
From
ScRNA-seq
SnRNA-seq
data,
31,390
48,221
nuclei
identified.
Analysis
differentially
expressed
genes
(DEGs)
revealed
significant
alterations
mice
with
affecting
hundreds
thousands
mRNAs
their
signalling
pathways.
Enrichment
analysis
indicated
activation
stress
inflammatory
pathways
hippocampus,
while
axonal
neural
support
suppressed.
Xenium
demonstrated
all
247
across
mouse
brain
sections,
revealing
distributions
27
cell
types.
Integrated
DEGs
identified
via
three
techniques
that
Spp1
,
Trem2
Cd68
upregulated
data;
Penk
Sorcs3
Plekha2
Tle4
Sipa1l3
downregulated
data.
Conclusion
In
this
study,
high-resolution
single-cell
atlas
established,
potential
intrinsic
driving
TLE-associated
altered
interactions.
These
findings
valuable
insights
for
further
exploration
HS
epileptogenesis.
Journal of Cerebral Blood Flow & Metabolism,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 9, 2024
Single-cell
RNA
sequencing
(scRNA-seq)
is
a
high-throughput
transcriptomic
approach
with
the
power
to
identify
rare
cells,
discover
new
cellular
subclusters,
and
describe
novel
genes.
scRNA-seq
can
simultaneously
reveal
dynamic
shifts
in
phenotypes
heterogeneities
subtypes.
Since
publication
of
first
protocol
on
2009,
this
evolving
technology
has
continued
improve,
through
use
cell-specific
barcodes,
adoption
droplet-based
systems,
development
advanced
computational
methods.
Despite
induction
stress
response
during
tissue
dissociation
process,
remains
popular
technology,
commercially
available
methods
have
been
applied
brain.
Recent
advances
spatial
transcriptomics
now
allow
researcher
capture
positional
context
transcriptional
activity,
strengthening
our
knowledge
organization
cell-cell
interactions
spatially
intact
tissues.
A
combination
data
proteomic,
metabolomic,
or
chromatin
accessibility
promising
direction
for
future
research.
Herein,
we
provide
an
overview
workflow,
analyses
methods,
pros
cons
technology.
We
also
summarize
latest
achievements
stroke
acute
traumatic
brain
injury,
applications
transcriptomics.